Lucette Side Effects: Complete Safety Guide

When Do Side Effects Start? How Long Do They Last? Timeline, Contraindications & Food Interactions

Key Takeaways: Lucette Side Effects

  • Most common: Nausea, headache, breast tenderness, irregular bleeding, mood changes – usually improve within 2‑3 months.
  • Serious but rare: Blood clots (VTE/ATE), liver tumours, breast cancer – seek immediate help for warning signs.
  • Onset: Side effects typically begin in the first 1‑3 cycles; many resolve as your body adjusts.
  • Contraindications: Do not use if you have history of blood clots, migraine with aura, liver disease, or certain cancers.
  • Interactions: St John’s wort and some antibiotics/antivirals reduce effectiveness; grapefruit may increase oestrogen levels.

Lucette is a highly effective combined oral contraceptive, but like all medicines it can cause side effects. Understanding what to expect, when they occur, and when to seek help ensures safe use.

Important Medical Advice

Seek urgent medical attention if you experience: sudden chest pain, breathlessness, persistent leg swelling, severe headache, vision loss, or weakness on one side – these could be signs of a blood clot (venous thromboembolism). Also stop Lucette and contact a doctor if you develop jaundice, severe abdominal pain, or a lump in your breast.

Common, Uncommon & Rare Side Effects of Lucette

Based on the Patient Information Leaflet and clinical studies, side effects are categorised by frequency.

Common (may affect up to 1 in 10 women)

  • Menstrual disorders (irregular bleeding, spotting)
  • Breast pain or tenderness
  • Headache
  • Depressed mood
  • Migraine
  • Nausea
  • Thick, whitish vaginal discharge (vaginal candidiasis)

Uncommon (may affect up to 1 in 100 women)

  • Breast enlargement
  • Changes in libido
  • High or low blood pressure
  • Vomiting, diarrhoea
  • Acne, skin rash, itching, hair loss (alopecia)
  • Vaginal infection
  • Fluid retention (oedema)
  • Weight changes

Rare (may affect up to 1 in 1,000 women)

  • Allergic reactions (hypersensitivity), asthma
  • Breast secretion
  • Hearing impairment
  • Erythema nodosum (painful reddish skin nodules)
  • Erythema multiforme (target‑shaped rash)
  • Blood clots: deep vein thrombosis (DVT), pulmonary embolism (PE), heart attack, stroke, transient ischaemic attack (TIA), clots in liver, intestine, kidney or eye

🗒️ Note: The risk of blood clots with Lucette (containing drospirenone) is higher than with some other pills but still small – about 9‑12 per 10,000 women per year. See section 2 of the PIL for detailed risk factors.

When Do Lucette Side Effects Start?

Most side effects appear during the first 1‑3 months of use as your body adjusts to the hormones. Nausea, breast tenderness, and headache often begin within the first few days of starting the first pack. Irregular bleeding (spotting) is most common in the first 3 months. Mood changes may also be noticed early. Serious side effects like blood clots can occur at any time, but the risk is highest during the first year of use or after a break of 4+ weeks.

How Long Do Lucette Side Effects Last?

Most mild side effects are temporary and resolve within 2‑3 months as your body acclimatises. Nausea usually subsides after the first few weeks. Breakthrough bleeding often decreases after cycle 3. If side effects persist beyond 3 months or become bothersome, consult your doctor – a different pill may be better tolerated. Serious side effects require immediate medical attention and usually resolve after stopping the pill, though some (like clots) may have lasting consequences.

Lucette Side Effects Timeline

Time PeriodCommon Experiences
Days 1‑7Nausea, headache, breast tenderness may begin. If started on day 1, protection immediate.
Cycles 1‑3Irregular bleeding/spotting common. Mood changes, acne may appear or improve. Most side effects peak then fade.
After 3 monthsIf side effects persist, they may be ongoing; discuss with doctor. Bleeding usually becomes regular and lighter.
Long‑term useRisk of blood clots remains low but present. Slight increase in breast cancer risk returns to normal after stopping.

Contraindications: Who Should NOT Take Lucette

Do not use Lucette if any of the following apply (adapted from the PIL):

  • Current or past blood clot in leg (DVT), lung (PE), or other organs
  • Known clotting disorder (e.g., protein C/S deficiency, Factor V Leiden, antiphospholipid antibodies)
  • Previous heart attack, stroke, angina, or transient ischaemic attack (TIA)
  • Migraine with aura (increased stroke risk)
  • Severe diabetes with blood vessel damage
  • Very high blood pressure or very high blood fats (cholesterol/triglycerides)
  • Liver disease or liver tumour (benign or malignant)
  • Kidney failure (severe renal impairment)
  • Hormone‑sensitive cancer (e.g., breast cancer) or suspected
  • Unexplained vaginal bleeding
  • Allergy to ethinylestradiol, drospirenone, or any excipients (especially soya lecithin – do not use if allergic to peanut or soya)
  • Taking hepatitis C medicines containing ombitasvir/paritaprevir/ritonavir, dasabuvir, glecaprevir/pibrentasvir, or sofosbuvir/velpatasvir/voxilaprevir

Food and Drug Interactions with Lucette

Food interactions

Lucette can be taken with or without food. Grapefruit juice may slightly increase ethinylestradiol levels, but this is not clinically significant for most women. No specific foods are prohibited.

Drug interactions that reduce efficacy

  • Enzyme inducers: rifampicin, rifabutin, barbiturates, carbamazepine, phenytoin, primidone, topiramate, oxcarbazepine, felbamate
  • HIV/HCV drugs: certain protease inhibitors, non‑nucleoside reverse transcriptase inhibitors (e.g., ritonavir, nevirapine, efavirenz)
  • Bosentan (for pulmonary hypertension)
  • Griseofulvin (antifungal)
  • St John’s wort (Hypericum perforatum) – herbal remedy

Drugs that may increase side effects

  • Paracetamol, ascorbic acid, atorvastatin – may increase ethinylestradiol levels (usually not clinically significant)

Always inform your doctor or pharmacist about all medicines you take, including herbal products. If you need short‑term treatment with an enzyme inducer, additional contraception (condoms) is recommended during and for 28 days after stopping.

Lucette Side Effects FAQs

Unlike older pills, drospirenone has anti‑mineralocorticoid properties that counteract water retention. Most women do not gain weight; some even report a slight decrease. Appetite changes may occur.

Mood changes, including depression, have been reported. If you experience severe mood swings or depressive thoughts, contact your doctor. Some women find drospirenone pills better tolerated for mood.

Spotting or light bleeding is common in the first 3 months. If it persists beyond 3 months or becomes heavy, see your doctor to rule out other causes.

Only if blood pressure is well controlled and there is no other vascular risk. Very high BP is a contraindication. Your doctor will monitor you closely.

If you have taken all pills correctly and miss a withdrawal bleed, it's unlikely you're pregnant. If you miss two consecutive bleeds, take a pregnancy test and consult your doctor.

Need Lucette with Expert Guidance?

If you are considering Lucette for contraception, our UK‑registered doctors can assess your suitability and provide a prescription online after a consultation.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Contraception Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 17 March 2026

Next Review: 17 September 2026

Published on: 17 March 2026

Last Updated: 17 March 2026